Current Diabetes Reviews
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.6 | Q3 | 36.5% | 0.660 | Q3 | 70.9% |
| 2024 | 1.9 | Q3 | 26.4% | 0.672 | Q3 | 72.2% |
| 2023 | 2.4 | Q3 | 39.2% | 0.765 | Q2 | 78.4% |
| 2022 | 3.3 | 49.2% | 0.696 | Q2 | 76.7% | |
| 2021 | — | 27.0% | 0.505 | Q3 | 67.3% | |
| 2020 | — | — | 0.631 | Q3 | 73.2% | |
| 2019 | — | — | 0.687 | Q2 | 76.4% | |
| 2018 | — | — | 0.733 | Q2 | 76.2% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1875-6417
ISSN
1573-3998
country
AEcoverage
1996, 2005-2026